TSX:TLRY (Aphria)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Aphria (TSX: TLRY) Latest News

Cannabis Stocks
TLRY Stock: Should You Invest Now?

Cannabis Stocks
Is Tilray Stock a Buy in February 2023?

Cannabis Stocks
TLRY Stock: Here’s What’s Coming in 2023

Cannabis Stocks
Better Cannabis Buy: Canopy Growth Stock or Tilray?

Energy Stocks
TSX Today: What to Watch for in Stocks on Tuesday, January 10

Cannabis Stocks
Is Tilray Stock a Buy in January 2023?

Stocks for Beginners
TSX Today: Why Canadian Stocks Could Continue Rallying on Monday, January 9

Cannabis Stocks
Why Tilray Stock Fell Almost 60% in 2022

Cannabis Stocks
The Investment Window Is Closing on 3 Big-Name Cannabis Stocks

Cannabis Stocks
Is Tilray Stock a Buy In December 2022?

Cannabis Stocks
Cannabis Stocks – Should Investors Buy Before 2023?
